What Researchers Need to Know for the Week of May 16, 2022 - Vibrent
Blog | May 16, 2022

What Researchers Need to Know for the Week of May 16, 2022

It’s been just a few weeks since the All of Us Research Program announced the availability of its first dataset, and researchers are already taking advantage of the program to make discoveries. This past week, we found that researchers have used that dataset to begin making predictive models to help identify patients in most need of additional resources at time of discharge. How else will the vast data from the All of Us program be used?
Elsewhere in the research community, we also discovered headlines revealing that the National Science Foundation is seeing declining demand for funding, a deep dive into the FDA’s latest guidance on diversity in clinical trials, and more.

All of Us Research Program News

All of Us research program celebrates four years at Emory

The All of Us effort has now enrolled more than 489,900 participants. In March, the program released its first genomic dataset, bringing around 100,000 whole-genome sequences onto its researcher workbench platform. Emory researchers played a significant role in this milestone, nurturing relationships with more than 7,000 diverse participants throughout metro Atlanta to ensure strong diversity in the dataset. Emory University, part of the SouthEast Enrollment Center (SEEC) of All of Us, has now enrolled nearly 40,000 collective participants since the launch.

Social determinants of health may help predict sepsis readmission

Researchers from the University of California, San Diego in a recent study where they used data from the National Institutes of Health’s All of Us research program cohort found that factors such as lack of insurance, economic instability, and poor transportation to obtain care were associated with 30-day readmission. They also found that including various social determinants of health improved the model’s ability to predict which sepsis patients are at risk and which patients may benefit from additional resources around the time of discharge, or post-discharge.

Diversity in Research

Five Things Researchers Need to Know about the FDA’s Updated Diversity Plans Guidance

The FDA released an updated guidance recently, and this is just one more in a number of recent government actions that point to a broader priority of improving diversity in health, and health research in particular.
Though the current FDA guidance is focused on clinical trials, researchers involved in longitudinal studies or observational studies, among other areas outside of clinical trials should still take notice. There are five key themes ranging from who the FDA’s guidance is currently targeting to how to be compliant – all covered in this article.

Research Funding

Odds improve for winning NSF grants, but drop in applications troubles some observers

A new report from the National Science Foundation (NSF) on its merit review system reveals that reduced demand has boosted success rates for research applications at the government agency. Changes in the biology directorate are the most remarkable. Demand for funding in biology has dropped by 50% over the past decade, while the odds of securing a grant for funding have doubled, from 18% to 36%.

AI & Machine Learning in Research

As problems emerge in medical AI models, research points to a new way to strip them of bias

After an explosion of excitement about the potential for machine learning in medicine, cracks in the foundation are emerging. More and more researchers are focusing on the ways that medical models can introduce algorithmic bias into health care. But in a new paper, machine learning researchers caution that such self-reflection is often ad hoc and incomplete. They argue that to get “an unbiased judgment of AI bias,” there needs to be a more routine and robust ways of analyzing how well algorithms perform. Without a standardized process, researchers will only find the bias they think to look for.

More to read

Paper Newly Published in JMIR Demonstrates the Efficacy of Digital Platforms to Increase Engagement with Diverse Populations in Health Research
Scientific Publication

Paper Newly Published in JMIR Demonstrates the Efficacy of Digital Platforms to Increase Engagement with Diverse Populations in Health Research

FAIRFAX, Va.--25 Jan., 2025--A pioneering study titled "Building a Digital Health Research Platform to Enable Recruitment, Enrollment, Data Collection, and…

Case Study

Transforming a National Lung Cancer Registry for Scale, Inclusion, and Real-World Research Impact 

How Vibrent modernized the GO2 registry to fulfill its mission of patient advocacy, patient support/education and research. ObjectivesMigrate existing data…

Case Study

Transforming Population Registries at Scale: Lessons from the All of Us Program (US NIH)

How Vibrent’s platform powered the most diverse, digital-first cohort in US history—and what it means for UK’s registries Problem: UK…

Press Release

Vibrent Health partners with Fred Hutchinson Cancer Center to Validate a Landmark BARDA-funded Large-Scale Hybrid/Remote Approach for NextGen Clinical Research

Bringing Infectious Disease Research to People Where They Live and Play FAIRFAX, Va.--12 Feb., 2025--Vibrent Health, a leading software-as-a-service SaaS…

Blog

eConsent Done Right: A Powerful Tool to Build Trust and Diversity in Research 

Researchers use a variety of tools and techniques to reach out and recruit diverse participants to their studies. But the…

Case Study

St. Jude Chooses Vibrent to Power the Next-Generation of the Childhood Cancer Long-Term Follow-Up Study 

OverviewSt. Jude Children’s Research Hospital has long been a leader in pediatric cancer research and survivorship care. One of its…

Blog

Are Your Digital Tools an Unintended Barrier to Diversity in Research? How to Bridge the Technology Gap for Research Participants

Since the start of the pandemic, researchers have faced additional challenges in participant recruitment and engagement. Safety and exposure concerns…

Case Study

Modernizing Remote and Hybrid Clinical Trials Sponsored by the US Biomedical Advanced Research and Development Authority (BARDA) for Mission-Critical Infectious Disease Studies  

Problem StatementTraditional site-based clinical trials faced challenges such as limited reach, high costs, prolonged timelines, significant patient burden due to…

Blog

To Recruit Diverse Research Participants, Get Out of the Clinic and into Your Community

Most research studies are performed in clinic-based academic medical center facilities. Centralizing resources – technology, laboratory facilities, and skilled clinical…

Case Study

Reducing the burden and cost of mental healthcare in the UK

The Challenge: A System  Under StrainAccording to BMA, good mental health is essential to a functioning society. Mental health problems…

SCROLL